HAMP and chronic kidney disease: Roxadustat (FG-4592, FibroGen, San Francisco, CA, USA), other oral HIF-PHD inhibitor, decreased hepcidin, ferritin and TSAT and increased Hb and TIBC in iron-replete ND-CKD patients not receiving IIT and ESA [211].